🇺🇸 FDA
Patent

US 8703735

Antisense antiviral compounds and methods for treating a filovirus infection

granted A61KA61K31/675A61K31/713

Quick answer

US patent 8703735 (Antisense antiviral compounds and methods for treating a filovirus infection) held by Sarepta Therapeutics, Inc. expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/675, A61K31/713, A61P, A61P31/00